ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

新着情報News

【Medchemexpress】New Bioactive Molecules for October 2024

  • 2024/10/16
  • サプライヤニュース

新着情報一覧へ

 

MedChemExpress - Master of Bioactive Molecules (Inhibitors. Screening Libraries. Proteins)

MedChemExpress (MCE) provides a wide range of life-science biochemicals, including more than 100,000 bioactive compounds, dye reagents, peptides and natural compounds for laboratory and scientific use. If you need these products, please do not hesitate to contact us via sales@MedChemExpress.com.

CAS No.: 2938995-50-5

BN-104

 

Research Area: Epigenetic Reader Domain/Menin-MLL/Acute Leukemias

BN-104  structure

A highly selective and orally active menin-MLL inhibitor.

Shows very potent against leukemia cell lines with MLL-fusion protein and NPM1 mutant.

Has optimized drug-like properties and excellent efficacy in MV4-11 xenograft mouse model.

Solubility: DMSO: 100 mg/mL (175.24 mM; Need ultrasonic)

CAS No.: 2540881-21-6

UH15-38

 

Research Area: RIP kinase/RIPK3/Lung Inflammation

UH15-38 structure

A potent and selective RIPK3 inhibitor with an IC50 value of 20 nM.

Selectively blocks IAV (influenza A virus)-triggered necroptosis in alveolar epithelial cells in vivo.

Ameliorates IAV-induced lung inflammation while leaving viral clearance and other functions of the immune response.

Solubility: DMSO: 100 mg/mL (226.49 mM; Need ultrasonic)

CAS No.: 2763602-16-8

Icotrokinra

 

Research Area: Interleukin Related/IL-23 Receptor/Inflammation

Icotrokinra  structure

A selective and orally active IL-23 receptor antagonist with a Kd of 7.1 pM.

Inhibits IL-23-induced STAT3 phosphorylation in PMBCs (IC50=5.6 pM), and potently inhibits IL-23-induced generation of IFNγ and IL-17A.

Can be used for the study of immune-mediated inflammatory diseases driven by dysregulated IL-23 signaling.

Solubility: DMSO: 100 mg/mL (52.68 mM; Need ultrasonic)

MCE Peptides

 
 

Structural

Product Name

Description

Cyclo(CKLIIF) TFA

A dual inhibitor for hypoxia inducible factor (HIF) 1 and 2.

DPLG3

A specific chymotryptic-like β5i subunits inhibitor (IC50=9.4 nM).

   
 

MCE Natural Products

 
 

Obesity is a disease and a risk factor for other diseases, such as heart disease, diabetes and cancer. Therefore, controlling obesity is of great significance to many diseases, among which natural products have great potential in controlling obesity.

Product Name

Description

Puerarin

Inhibits the dorsal motor nucleus of vagus (DMV)-vagus pathway, which in turn leads to reduced fat absorption.

Hyperforin

Triggers thermogenesis in adipose tissue via a Dlat-AMPK signaling axis to curb obesity.

Equisetin

An anti-obesity agent through targeting 11β-HSD1.

Saikosaponin A

Improves obesity-related metabolic dysfunction by activating PPARγ.

Soyasaponin Ab

Exerts an anti-obesity effect in 3T3-L1 adipocytes through downregulation of PPARγ.

 

MCE Compound Library

 
 

Provide professional compound library, serving cancer, immunity, metabolism and other fields of research.

Product Name

Description

Structurally Diverse Fragment Library

Contains 2,300+ molecules with high structural diversity that meet ‘RO3’ criteria, which can be applied to fragment-based drug development.

Drug Fragment Library

Contains 1,000 drug fragments, all of which are derived from FDA-approved drug molecules. These fragments are correlated with good PK/PD properties. Besides, fragment-based screening can reserve enough chemical space for subsequent structural optimization.

Vitamin Compound Library

Contains 140+ vitamins and their derivatives, which can be used to build a platform for vitamin metabolism research, serving as a good tool to explore the metabolic pathways of vitamins within biological systems.

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Contains 3,100+ compounds have clear or potential anti-NAFLD activity, serving as essential tools for investigating the pathogenesis of NAFLD and for drug development.

Latest Publications Citing Use of MCE Products

Covers of Recent Publications

Nature.
2024 Aug;632(8027):1137-1144.

Nature.
2024 Aug;632(8026):903-910.

Nature.
2024 Aug;632(8026):930-937.

Nature.
2024 Aug;632(8026):893-902.

Cell.
2024 Sep 5;187(18):5064-5080.e14.

Cell Signaling Pathway

MCE USA

Tel: 609-228-6898

E-mail: sales@MedChemExpress.com

Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA

MCE Europe

Tel: +4686500910

E-mail: eu.sales@MedChemExpress.com

Address: Bergkällavägen 37C 192 79 Sollentuna SWEDEN

Join with us

i-twitter-0824

i-facebook

i-linkin

Products are for research use only and are not intended for human use. We do not sell to patients.
We respect your privacy and do not share or sell your information to third parties.

 

Medchemexpress(メドケムエクスプレス)社について

設立
2009年
本社所在地
アメリカ
URL
http://www.medchemexpress.com/

MedChemExpress(MCE)は、新規のライフサイエンス試薬、薬理活性化合物、APIなど高品質の研究化学物質および生化学物質を幅広く提供しております。MCE のテクニカルサポートチームは経験が豊富であり、ライフサイエンス業界においては長年の経験を積んでおります。

ご不明点等ございましたら、お気軽にお問い合わせください。

お問い合わせ